Barclays »

Edgewise Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.5M 779k 10.95
2023-09-30 $105k 18k 5.74
2023-06-30 $133k 17k 7.70
2023-03-31 $189k 28k 6.73
2022-12-31 $163k 18k 8.94
2022-09-30 $91k 9.3k 9.77
2022-06-30 $1.7M 219k 7.96
2022-03-31 $2.1M 220k 9.70